Rajesh Israni Email

SVP, Head Regulatory Affairs and Medical Writing . Dragonfly Therapeutics

Current Roles

Employees:
132
Revenue:
$20.5M
About
Dragonfly Therapeutics is a discovery-stage company developing drugs to stimulate immune responses against cancer. We are developing novel first-in-class therapeutics targeted at natural killer cells and other cells of the innate immune system. These therapies are designed to counterbalance immune suppressive factors present in the tumor microenvironment and mobilize anti-cancer immune responses. Our molecules are expected to be potent as single agents as well as in treatment combinations with existing cancer immunotherapies. Our scientific founders are major figures in cancer biology and immunology and have launched Dragonfly to harness the power of the immune system to provide breakthrough cancer treatments for patients. For more information, email info@dragonflytx.com.
Dragonfly Therapeutics Address
35 Gatehouse Drive
Waltham, MA
United States
Dragonfly Therapeutics Email

Past Companies

Dragonfly Therapeutics, Inc.Senior Vice President, Head of Regulatory Affairs and Medical Writing
Dragonfly Therapeutics, Inc.VP, Head of Regulatory Affairs
Zai LabVP, Head of Regulatory Affairs US and EU

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.